# OnCo record paper-gotfrit-cancer-drug-access-pathway-canada-curr-oncol-2022 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-gotfrit-cancer-drug-access-pathway-canada-curr-oncol-2022/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-gotfrit-cancer-drug-access-pathway-canada-curr-oncol-2022" ;
  schema:name "The pathway for new cancer drug access in Canada"@en ;
  schema:description "A plain map of the steps a new cancer drug passes through in Canada, from Health Canada's licence and the federal price ceiling through the national value review and joint price negotiation to each province's decision to pay."@en ;
  schema:url <https://onco.cc/key-papers/paper-gotfrit-cancer-drug-access-pathway-canada-curr-oncol-2022/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://doi.org/10.3390/curroncol29020041>, <https://pubmed.ncbi.nlm.nih.gov/35200541/> ;
  schema:sameAs <https://doi.org/10.3390/curroncol29020041> ;
  schema:datePublished "2022"^^xsd:gYear ;
  schema:author "Gotfrit J, Dempster W, Chambers J, Wheatley-Price P" ;
  onco:institutions <https://onco.cc/institutions/health-canada/>, <https://onco.cc/institutions/cda-amc/>, <https://onco.cc/institutions/inesss/> ;
  onco:journals <https://onco.cc/journals/current-oncology-mdpi/> .